Etoposide and Subdural hygroma - a phase IV clinical study of FDA data

Summary:

Subdural hygroma is reported as a side effect among people who take Etoposide (etoposide), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Methotrexate, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Subdural hygroma when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Subdural hygroma?

Subdural hygroma (subdural collection of cerebrospinal fluid (csf), without blood) is found to be associated with 40 drugs and 170 conditions by eHealthMe. Check the latest studies of Subdural hygroma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 25 people (0.03%) have Subdural hygroma.

Could Etoposide cause Subdural hygroma?

Among these 25 people:

How long have people been on Etoposide when they have Subdural hygroma? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Subdural hygroma when taking Etoposide? *

  • female: 52.17 %
  • male: 47.83 %

What is the age of people who have Subdural hygroma when taking Etoposide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 4.35 %
  • 50-59: 82.61 %
  • 60+: 13.04 %

What are other drugs people take besides Etoposide? *

  1. Methotrexate: 9 people, 36.00%
  2. Prednisolone: 3 people, 12.00%
  3. Gleevec: 3 people, 12.00%
  4. Cyclophosphamide: 3 people, 12.00%
  5. Wellbutrin: 1 person, 4.00%
  6. Sodium Chloride: 1 person, 4.00%
  7. Lexapro: 1 person, 4.00%
  8. Imbruvica: 1 person, 4.00%
  9. Doxil: 1 person, 4.00%

What are other side effects people have besides Subdural hygroma? *

  1. Febrile Neutropenia (fever with reduced white blood cells): 13 people, 52.00%
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 8 people, 32.00%
  3. Thrombocytopenia (decrease of platelets in blood): 8 people, 32.00%
  4. Haemorrhage (bleeding): 7 people, 28.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 24.00%
  6. Multi-Organ Failure (multisystem organ failure): 5 people, 20.00%
  7. Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 4 people, 16.00%
  8. Headache (pain in head): 4 people, 16.00%
  9. Subdural Haematoma (blood collects between the skull and the surface of the brain): 4 people, 16.00%
  10. Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 16.00%

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 10 people, 40.00%
  2. Burkitt Lymphoma (cancer of the lymphatic system): 10 people, 40.00%
  3. Tumor Lysis Syndrome: 9 people, 36.00%
  4. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 36.00%
  5. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 12.00%
  6. Lymphoma (cancer that begins in immune system cells): 1 person, 4.00%
  7. Leukaemic Lymphoma (a rare cancer of the immune systems own t-cells): 1 person, 4.00%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.00%
  9. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.00%
  10. Affective Disorder (mental disorder): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Subdural hygroma?

- Check whether Subdural hygroma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Subdural hygroma treatments and more:

How severe was Subdural hygroma and when was it recovered:

Expand to all the drugs that have ingredients of etoposide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subdural hygroma:

Browse all the conditions that are associated with Subdural hygroma:


How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: